Work

Evaluating the Impact of Lab-Based Eligibility Criteria By Race/Ethnicity in Frontline Clinical Trials for Diffuse Large B-Cell Lymphoma (DLBCL): A LEO Cohort Analysis

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-169433

Authors: Arushi Khurana, Raphael Mwangi, Loretta J. Nastoupil, Patrick M. Reagan, Umar Farooq, Jason T. Romancik, Timothy J. McDonnell, Shaun M Riska, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Thomas E. Witzig, James R. Cerhan, Christopher R. Flowers, Matthew J. Maurer, Grzegorz S. Nowakowski

Institutions: Mayo Clinic, The University of Texas MD Anderson Cancer Center, University of Rochester Medicine, University of Iowa, Emory University, Winship Cancer Institute, University of Miami, Sylvester Comprehensive Cancer Center, Washington University in St. Louis, NewYork–Presbyterian Hospital, Weill Cornell Medicine, Weill Cornell Medical Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W4310104220

FWCI: 0.282

Cites:

Cited by: 2

Related to: 10